Surveillance of Candida spp bloodstream infections: Epidemiological trends and risk factors of death in two Mexican tertiary care hospitals

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Corzo Leon, Dora E ^a   Alvarado Matute, Tito ^b   Colombo, Arnaldo L ^c   Cornejo Juarez, Patricia ^d   Cortes, Jorge ^e   Echevarria, Juan I ^f   Guzman Blanco, Manuel ^g   Macias, Alejandro E ^a   Nucci, Marcio ^h   Ostrosky Zeichner, Luis ⁱ   Ponce de Leon, Alfredo ^a   Queiroz Telles, Flavio ^j   Santolaya, Maria E ^k   Thompson Moya, Luis ^l   Tiraboschi, Iris N ^m   Zurita, Jeannete ⁿ   Sifuentes Osornio, Jose ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Hospital Escuela   (Honduras)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^e UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^f UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^g Hospital Vargas de Caracas   (Venezuela)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^j FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^k UNIVERSITY OF CHILE   (Chile)

^l UNIVERSIDAD DEL DESARROLLO   (Chile)

^m HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

ⁿ PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B; AMPHOTERICIN B, DEOXYCHOLATE DRUG COMBINATION; DEOXYCHOLIC ACID; DRUG COMBINATION; FLUCONAZOLE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; APACHE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; DEATH; DIABETES MELLITUS; DISEASE SURVEILLANCE; FUNGUS IDENTIFICATION; HUMAN; INCIDENCE; LIVER DISEASE; MAJOR CLINICAL STUDY; MEXICO; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RANK SUM TEST; RISK FACTOR; STUDENT T TEST; TERTIARY CARE CENTER; AGED; CANDIDA; CANDIDIASIS; CHEMISTRY; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AMPHOTERICIN B; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; DEOXYCHOLIC ACID; DRUG COMBINATIONS; FEMALE; FLUCONAZOLE; HUMANS; INCIDENCE; MALE; MEXICO; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84901301026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097325     Document Type: Article

References (34)

1. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
2. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, et al. (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37: 1612-1618.
3. Lipsett PA (2006) Surgical critical care: fungal infections in surgical patients. Crit Care Med 34(9 Suppl): S215-24.
4. Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, et al. (2009) The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther 16: 508-511.
5. Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, et al. (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44: 2816-2823.
6. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48: 1695-1703.
7. Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL (2010) Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 51: 561-570.
8. Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrel M, et al. (2007) Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med 35: 1077-1083.
9. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, et al. (2013) Epidemiology of candidemia in Latin-America: a laboratory-based survey. PLos One 8: e59374. doi: 10.1371/journal.pone.0059373.
10. Gonzalez GM, Elizondo M, Ayala J (2008) Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 46: 2902-2905.
11. Ayala-Gaytan JJ, Aleman-Bocanegra MC, Guajardo-Lara CE, Valdovinos-Chavez SB (2010) Catheter-associated bloodstream infections. Review of five-year surveillance among hospitalized patients. Rev Med Inst Mex Seguro Soc 48: 145-50.
12. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, et al. (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49: 1-45.
13. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - Third Edition. CLSI document M27-A3 (ISBN 1-56238-666-2). Third ed. Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute.
14. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, et al. (2004) Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 38: 311-320.
15. Ostrosky-Zeichner L, Pappas PG (2006) Invasive candidiasis in the intensive care unit. Crit Care Med 34: 857-863.
16. Colombo AL, Guimarães T, Silva LR, de Almeida-Monfardini LP, Cunha AK, et al. (2007) Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 28: 570-576.
17. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, et al. (2008) Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46: 1206-1213.
18. Faiz S, Neale B, Rios E, Campos T, Parsley E, et al. (2009) Risk- based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 28: 689-692.
19. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, et al. (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37: 634-643.
20. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, et al. (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55: 532-538.
21. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, et al. (2001) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 39: 3254-3259.
22. Volkow P, Sanchez-Mejorada G, de la Vega SL, Vazquez C, Tellez O, et al. (1994) Experience of an intravenous therapy team at the Instituto Nacional de Cancerologia (Mexico) with a long-lasting, low-cost silastic venous catheter. Clin Infect Dis 18: 719-725.
23. Macias AE, Huertas M, de Leon SP, Munoz JM, Chavez AR, et al. (2010) Contamination of intravenous fluids: a continuing cause of hospital bacteremia. Am J Infect Control 38: 217-221.
24. Wenzel RP, Gennings C (2005) Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis (Suppl 6): S389-93.
25. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, et al. (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6: 21. doi:10.1186/1471-2334-6-21
26. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, et al. (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi- institutional study. Clin Infect Dis 43: 25-31.
27. Dimopoulos G, Karabinis A, Samonis G, Falagas ME (2007) Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis 26: 377-384.
28. Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, et al. (2009) Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 15: 47-53.
29. Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, et al. (2012) Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection 40: 271-278.
30. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, et al. (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48: 503-535.
31. Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, et al. (2004) Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38: 1119-1127.
32. Zaas AK, Dodds Ashley ES, Alexander BD, Johnson MD, Perfect JR (2006) Caspofungin for invasive candidiasis at a tertiary care medical center. Am J Med 119: 993.e1-993.e6.
33. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, et al. (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48: 1366-1377.
34. Pfaller MA, Diekema DJ (2012) Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 50: 2846-2856.